Literature DB >> 8237059

Biological fate of sulphur mustard in rat: toxicokinetics and disposition.

A Maisonneuve1, I Callebat, L Debordes, L Coppet.   

Abstract

1. The toxicokinetics of sulphur mustard were studied after i.v. administration (10 mg/kg) to rat. 2. After i.v. administration, blood concentrations of sulphur mustard were best described by a two-compartment model with distribution and elimination half-lives of 5.6 min and 3.59 h, respectively. The apparent volume of distribution at steady state (Vdss) was 74.4 l/kg and total body clearance (Cl) was 21 l/h kg-1. 3. Unchanged sulphur mustard was still detectable in the systemic circulation 8 h after administration. Appreciable and long (96 h) accumulation of 14C was found in the systemic circulation, and significant high affinity of 14C-sulphur mustard for red blood cells. 4. The disposition of 14C was also investigated after i.v. injection of 14C-sulphur mustard to rat. Urine was the major route of excretion of sulphur mustard and/or its metabolites. Of the administered radioactivity 80% was excreted in urine over 96 h, the greater part in the first 24 h after administration. Residual 14C continued to be excreted until 4 days later. In urine, no sulpho- or glucuronyl-conjugates were detected. Of dose < 3% was recovered in faeces.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8237059     DOI: 10.3109/00498259309166783

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  7 in total

1.  An enhanced throughput method for quantification of sulfur mustard adducts to human serum albumin via isotope dilution tandem mass spectrometry.

Authors:  Tracy M Andacht; Brooke G Pantazides; Brian S Crow; Alex Fidder; Daan Noort; Jerry D Thomas; Thomas A Blake; Rudolph C Johnson
Journal:  J Anal Toxicol       Date:  2013-11-07       Impact factor: 3.367

2.  Mustard gas crosslinking of proteins through preferential alkylation of cysteines.

Authors:  M P Byrne; C A Broomfield; W E Stites
Journal:  J Protein Chem       Date:  1996-02

3.  Treatment with the catalytic metalloporphyrin AEOL 10150 reduces inflammation and oxidative stress due to inhalation of the sulfur mustard analog 2-chloroethyl ethyl sulfide.

Authors:  Heidi C O'Neill; Carl W White; Livia A Veress; Tara B Hendry-Hofer; Joan E Loader; Elysia Min; Jie Huang; Raymond C Rancourt; Brian J Day
Journal:  Free Radic Biol Med       Date:  2010-02-04       Impact factor: 7.376

4.  A case control study of cardiovascular health in chemical war disabled Iranian victims.

Authors:  Atoosheh Rohani; Vahid Akbari; Fatemeh Tabesh Moghadam
Journal:  Indian J Crit Care Med       Date:  2010-07

5.  The injury progression of T lymphocytes in a mouse model with subcutaneous injection of a high dose of sulfur mustard.

Authors:  Yi-Zhou Mei; Xiao-Rui Zhang; Ning Jiang; Jun-Ping Cheng; Feng Liu; Pan Zheng; Wen-Xia Zhou; Yong-Xiang Zhang
Journal:  Mil Med Res       Date:  2014-12-19

6.  Sulfur mustard research--strategies for the development of improved medical therapy.

Authors:  Kai Kehe; Frank Balszuweit; Judith Emmler; Helmut Kreppel; Marianne Jochum; Horst Thiermann
Journal:  Eplasty       Date:  2008-06-10

7.  Four sulfur mustard exposure cases: Overall analysis of four types of biomarkers in clinical samples provides positive implication for early diagnosis and treatment monitoring.

Authors:  Hua Xu; Zhiyong Nie; Yajiao Zhang; Chunzheng Li; Lijun Yue; Wenfeng Yang; Jia Chen; Yuan Dong; Qin Liu; Ying Lin; Bidong Wu; Jianlin Feng; Hua Li; Lei Guo; Jianwei Xie
Journal:  Toxicol Rep       Date:  2014-08-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.